Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Dec;66(6):1724-1726.
doi: 10.1002/hep.29411. Epub 2017 Oct 30.

Beyond Farnesoid X receptor to target new therapies for NAFLD

Xiaoying Liu  1 , Richard M Green  1
Affiliations
Editorial

Beyond Farnesoid X receptor to target new therapies for NAFLD

Xiaoying Liu et al. Hepatology. 2017 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Akinrotimi O, Riessen R, VanDuyne P, Park JE, Lee YK, Wong LJ, Zavacki AM, et al. Shp deletion prevents hepatic steatosis and when combined with Fxr loss protects against type 2 diabetes. Hepatology. 2017 - PMC - PubMed
    1. Anakk S, Watanabe M, Ochsner SA, McKenna NJ, Finegold MJ, Moore DD. Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis. J Clin Invest. 2011;121:86–95. - PMC - PubMed
    1. Kim KH, Choi S, Zhou Y, Kim EY, Lee JM, Saha PK, Anakk S, et al. Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice. Hepatology. 2017 - PMC - PubMed
    1. Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, Willson TM, et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci U S A. 2006;103:1006–1011. - PMC - PubMed
    1. Watanabe M, Horai Y, Houten SM, Morimoto K, Sugizaki T, Arita E, Mataki C, et al. Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem. 2011;286:26913–26920. - PMC - PubMed

MeSH terms

Substances